This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Estimates Rising for Cabot (CBT): Will It Gain?
by Zacks Equity Research
Cabot (CBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Cabot (CBT) Is Up 1.45% in One Week: What You Should Know
by Zacks Equity Research
Does Cabot (CBT) have what it takes to be a top stock pick for momentum investors? Let's find out.
New Strong Buy Stocks for February 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Is Cabot (CBT) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Is (CBT) Outperforming Other Basic Materials Stocks This Year?
New Strong Buy Stocks for February 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
BHP Group (BHP) Earnings Up Y/Y in First Half of Fiscal 2021
by Zacks Equity Research
BHP Group's (BHP) earnings in the first half of fiscal 2021 gain on higher prices and a stellar production performance. Favorable commodity prices and demand are likely to buoy fiscal 2021 performance.
Looking for a Growth Stock? 3 Reasons Why Cabot (CBT) is a Solid Choice
by Zacks Equity Research
Cabot (CBT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
New Strong Buy Stocks for February 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Cabot (CBT) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Cabot (CBT) Q1 results benefit from strength in volumes and strong Reinforcement Material unit margins.
Cabot (CBT) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 35.63% and 7.87%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Cabot (CBT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cabot's (CBT) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Cabot Corporation (CBT).
Global Chemical Output Leaps for Sixth Straight Month: 5 Picks
by Anindya Barman
The chemical industry has recovered from the pandemic-led slump and looks set for an upturn this year on a rebound in end-market demand. CBT, HUN, CC, PPG and CE to gain from the industry's recovery.
4 Relative Price Strength Stocks to Make You Rich in 2021
by Nilanjan Choudhury
Cabot (CBT), Myers Industries (MYE), Target (TGT) and Vale (VALE) are four stocks with explosive relative price strength.
Why You Should Add Cabot (CBT) Stock to Your Portfolio Now
by Zacks Equity Research
Cabot (CBT) gains from a demand recovery in the automotive market and the Shenzhen Sanshun Nano acquisition.
4 Diversified Chemical Stocks Set to Ride the Industry's Upturn
by Anindya Barman
An uptick in demand in key end-markets from pandemic-led shocks should enable the Zacks Chemicals Diversified industry to thrive. PPG, CC, CBT and KOP are set to gain from improving industry fundamentals and strategic actions.
Lithium Americas (LAC) Catches Eye: Stock Jumps 9.5%
by Zacks Equity Research
Lithium Americas (LAC) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Why Is Cabot (CBT) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Consider Cabot (CBT) Stock Now?
by Zacks Equity Research
Let's see if Cabot (CBT) stock is a good choice for value-oriented investors right now from multiple angles.
US Chemical Industry to Stage a Turnaround in 2021: 4 Picks
by Zacks Equity Research
The chemicals industry is set to stage a rebound on the back of positive macroeconomic developments, which makes the space a hotbed for money
US Chemical Industry Set for Strong Rebound in 2021: 5 Picks
by Anindya Barman
The U.S. chemical industry is poised for an upturn next year on a rebound across major end-markets and a recovery in chemical exports.
Here is Why Growth Investors Should Buy Cabot (CBT) Now
by Zacks Equity Research
Cabot (CBT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Zacks Analyst Blog Highlights: Bunge, Cabot Corp, International Paper, Neenah and Schnitzer Steel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bunge, Cabot Corp, International Paper, Neenah and Schnitzer Steel
3 Chemical Stocks to Benefit from Strength in Housing and Auto
by Sejuti Banerjea
The recovery in manufacturing activity across the world and particularly, in China (one of the largest consumers of chemicals is a positive for the industry and considering the improving prospects, some of these stocks are still going cheap.